ClinNEXUS
PrivateLast Round
Accelerator
Oct 20, 2022
Total Funding Raised
$100,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ClinNEXUS operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was an Accelerator round in October 2022.
ClinNEXUS is a healthcare technology company that provides a data-driven platform for care coordination, uniting clinical, social, and behavioral support for underserved communities.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Healthcare Analytics, Vertical SaaS, Telemedicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ClinNEXUS Comparables
Compare ClinNEXUS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sprite Health | 82% | |
| Waymark | 81% | |
| Pair Team | 81% |
For institutional investors. Book with your work email.
ClinNEXUS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 20, 2022 | ||||
| Seed | Sep 21, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ClinNEXUS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Suncoast Ventures | Seed |
| Expert Dojo | Seed, Accelerator |
| Suncoast Ventures | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 66% MoM.
- Aug 21, 2026
Grew 16% QoQ, from 37 to 43 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresAug 4, 2026
ClinNEXUS, Inc. appoints John Stamatopoulos as Chief Growth Officer in a new position focused on growth and partnership strategy across California on Aug 4th '26.
- hiresAug 4, 2026
ClinNEXUS, Inc. hires John for its leadership team as it reaches an inflection point for growth and expands care coordination with strategic partners.
For institutional investors. Book with your work email.
ClinNEXUS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ClinNEXUS's valuation, stock price, and market status.
Is ClinNEXUS a public or private company?
ClinNEXUS is a private company.
What is the current stock price of ClinNEXUS?
ClinNEXUS is a private company, so its shares have no public market price. Caplight tracks ClinNEXUS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ClinNEXUS worth (valuation)?
Valuation information for ClinNEXUS is not publicly available.
Can I buy ClinNEXUS stock?
ClinNEXUS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ClinNEXUS's last funding round?
ClinNEXUS's most recent funding round was Accelerator on October 20, 2022.
Who are the main investors in ClinNEXUS?
Key investors in ClinNEXUS include Expert Dojo.
Will ClinNEXUS IPO soon?
No public IPO plans have been announced for ClinNEXUS.
How can I track ClinNEXUS secondary market activity?
Caplight tracks bids, offers, and trades in ClinNEXUS's shares on secondary markets.